Table 3. Patients with positive SLN, non-SLN compromise according to clinicopathological subtype.

Metastasis in SLN		Patients with ALND		Patients with nonSLN+
Molecular Profile	n	n	%	n	%	p*
Luminal A	85	75	88.2	31	41.3	----
Luminal B	80	71	88.8	33	46.5	0.53
Luminal not specified	23	20	87.0	5	25.0	0.18
HER2	4	4	100.0	2	50.0	0.73
Triple negative	15	14	93.3	8	57.1	0.27
Total	207	184	88.9	79	42.9

SLN: sentinel lymph node,

non-SLN: non sentinel lymph node,

ALND: axillary lymph node dissection.

^*p value calculated based on chi-square test.

All profiles were compared to luminal A.